Jiangsu Wuzhong Pharmaceutical Development Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000000YP4
CNY
1.24
0.06 (5.08%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
314.19
312.97
315.93
436.21
497.43
421.90
732.97
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
314.19
312.97
315.93
436.21
497.43
421.90
732.97
Raw Material Cost
116.25
121.61
0.00
232.53
302.20
278.32
625.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
15.98
17.17
0.00
17.52
18.83
22.79
19.04
Selling and Distribution Expenses
131.93
240.31
0.00
161.35
154.67
108.00
162.49
Other Expenses
-0.26
-0.59
0.00
-0.76
-0.95
-0.74
-0.81
Total Expenditure (Excl Depreciation)
261.60
373.20
0.00
403.82
466.15
401.74
798.55
Operating Profit (PBDIT) excl Other Income
52.599999999999994
-60.199999999999996
315.9
32.400000000000006
31.299999999999997
20.2
-65.6
Other Income
3.38
4.82
0.00
7.43
8.10
9.30
9.46
Operating Profit (PBDIT)
71.80
-41.66
0.00
53.15
52.21
42.17
-45.69
Interest
15.98
17.17
0.00
17.52
18.83
22.79
19.04
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
197.95
191.36
0.00
203.68
195.24
137.32
107.83
Depreciation
14.30
14.30
0.00
13.15
12.87
12.87
11.97
Profit Before Tax
41.52
-73.12
0.00
22.47
20.51
6.51
-76.69
Tax
8.38
-6.87
0.00
0.12
0.23
0.60
0.28
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
25.90
-70.32
25.40
20.63
19.40
5.06
-82.90
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
25.90
-70.32
25.40
20.63
19.40
5.06
-82.90
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
7.74
4.50
0.00
1.95
0.48
-0.39
-1.02
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
33.64
-65.82
25.40
22.58
19.88
4.67
-83.92
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,769.40
1,752.87
1,823.07
1,796.22
1,775.65
1,750.24
1,744.01
Earnings per share (EPS)
0.04
-0.1
0.04
0.03
0.03
0.01
-0.12
Diluted Earnings per share
0.04
-0.1
0.04
0.03
0.03
0.01
-0.12
Operating Profit Margin (Excl OI)
17.22%
-19.42%
0.0%
7.47%
6.28%
4.74%
-9.16%
Gross Profit Margin
17.77%
-18.79%
0.0%
8.17%
6.71%
4.59%
-8.83%
PAT Margin
8.24%
-22.47%
8.04%
4.73%
3.9%
1.2%
-11.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.38% vs -0.92% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 151.06% vs -359.06% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 247.10% vs 0.00% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is -6.98% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Jiangsu Wuzhong Pharmaceutical Development Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
314.19
0
314.19
Other Operating Income
0.00
0.00
0.00
Total Operating income
314.19
0
314.19
Raw Material Cost
116.25
0
116.25
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
15.98
0
15.98
Selling and Distribution Expenses
131.93
0
131.93
Other Expenses
-0.26
0.00
-0.26
Total Expenditure (Excl Depreciation)
261.60
0
261.60
Operating Profit (PBDIT) excl Other Income
52.59
0.00
52.59
Other Income
3.38
0
3.38
Operating Profit (PBDIT)
71.80
0
71.80
Interest
15.98
0
15.98
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
197.95
0
197.95
Depreciation
14.30
0
14.30
Profit Before Tax
41.52
0
41.52
Tax
8.38
0
8.38
Provisions and contingencies
0
0
0.00
Profit After Tax
25.90
0
25.90
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
25.90
0
25.90
Share in Profit of Associates
0
0
0.00
Minority Interest
7.74
0
7.74
Other related items
0.00
0.00
0.00
Consolidated Net Profit
33.64
0
33.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,769.40
0
1,769.40
Earnings per share (EPS)
0.04
0
0.04
Diluted Earnings per share
0.04
0
0.04
Operating Profit Margin (Excl OI)
17.22%
0%
0.00
17.22%
Gross Profit Margin
17.77%
0%
0.00
17.77%
PAT Margin
8.24%
0%
0.00
8.24%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 31.42 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.38% vs -0.92% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -36.83% vs 2.56% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.36 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 151.06% vs -359.06% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 68.84% vs 1,758.33% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.84 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 247.10% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 55.10% vs 82.99% in Jun 2024

Quarterly - Interest
Interest 1.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -6.98% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -14.89% vs 11.90% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.22%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024